Publications by authors named "Tim Koldenhof"

Claim this Profile
H
High heart rates during paroxysmal atrial fibrillation: continuous rhythm monitoring data of the RACE V study.
Tim Koldenhof, Isabelle C Van Gelder, Martijn E van de Lande, Meelad I H Al-Jazairi, Robert G Tieleman

Heart· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Previous Exercise Levels and Outcome in Patients with New Atrial Fibrillation: "Past Achievements Do Not Predict the Future".
Charlotte J Lenting, E P J Petra Wijtvliet, Tim Koldenhof, Bram Bessem, Nikki A H A Pluymaekers

Med Sci Sports Exerc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers.
Tim Koldenhof, Isabelle C Van Gelder, Harry Jgm Crijns, Michiel Rienstra, Robert G Tieleman

Heart· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation.
Maria Hee Jung Park Frausing, Martijn E Van De Lande, Alexander H Maass, Bao-Oanh Nguyen, Martin E W Hemels, Tim Koldenhof

Heart· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study.
Martijn E van de Lande, Rajiv S Rama, Tim Koldenhof, Vicente Artola Arita, Bao-Oanh Nguyen

Europace· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study.
Vicente Artola Arita, Martijn E Van De Lande, Neda Khalilian Ekrami, Bao-Oanh Nguyen, Joost M Van Melle, Tim Koldenhof

Europace· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate control drugs differ in the prevention of progression of atrial fibrillation.
Tim Koldenhof, Petra E P J Wijtvliet, Nikki A H A Pluymaekers, Michiel Rienstra, Richard J Folkeringa

Europace· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis